Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2/3 2Phase 2 2Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Diabetes Mellitus 2Vomiting 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Prostatic Neoplasms 1Premature Birth 1Pre-Eclampsia 1Polycystic Ovary Syndrome 1Parathyroid Neoplasms 1Neoplasms 1Medulloblastoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia, B-Cell 1Leiomyosarcoma 1Hyperparathyroidism, Primary 1Hot Flashes 1HER2 IHC3+ Advanced Colorectal Cancer 1Erectile Dysfunction 1Cognitive Dysfunction 1Carcinoma, Renal Cell 1

Interventions

Metformin 21Letrozole 11Clomiphene 7dapagliflozin 4Contraceptives, Oral 4Chorionic Gonadotropin 4cetrorelix 3Liraglutide 3Inositol 3follitropin beta 2follitropin alfa 2drospirenone and ethinyl estradiol combination 2Musculoskeletal Manipulations 2Glycoprotein Hormones, alpha Subunit 2DLBS3233 2Cholecalciferol 2semaglutide 1saxagliptin 1lime 1follicle stimulating hormone, human, with HCG C-terminal peptide 1drospirenone 1cinnulin PF 1Urofollitropin 1Triptorelin Pamoate 1Treatment Expectations 1Thioctic Acid 1Tamoxifen 1Tablets 1Sugars 1Sperm Injections, Intracytoplasmic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Polycystic Ovary Syndrome × Tablets × Clear all
NCT00159536 2019-02-15

PregMet

Norwegian University of Science and Technology

Phase 3 Completed
257 enrolled

Diabetes Mellitus, Polycystic Ovary Syndrome, Pre-Eclampsia, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡